Pharma News
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
-
-
Rice University Researchers reveal that Deep-diving whales may create synthetic blood. The study appears in the Journal of Biological Chemistry.
-
(NewsVoir); Necessity is the mother of all invention. Pharmaceuticals industry just got innovative in reaching out to doctors with the latest app for Apple Watch under the Ethical Marketing norms. Developed by Indegene, the leading provider of healthcare solutions to the global pharmaceuticals industry, medical insurers and hospitals in the US, has developed the latest app for the Apple Watch for the healthcare industry to engage with doctors. This app augurs well for the Pharma industry already reeling under pressures of compliance norms for ethical marketing to doctors.
-
Perrigo Company plc, received US Food and Drug Administration (FDA) approval for the generic version of Valeant Pharmaceutical International Inc's BenzaClin topical gel.
[adsense:336x280:8701650588]
-
Oculus Innovative Sciences, Inc., a specialty pharmaceutical company, introduce two new MicrocynAH dermatology products for animals.
-
A new study has suggested that survivors of childhood brain tumors have lower working memory performance in adulthood compared to healthy adults. The study appeared in the Journal of the International Neuropsychological Society.
-
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, has received 510(k) clearance for its second-generation, large-volume Infusomat Space Pump.
-
Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. New results show that these patients also do better regardless of their age, stage of disease and whether or not they have a cancer-driving mutation in the BRAF gene.
-
European Commission (EC) has granted marketing authorization for Praluent® (alirocumab) for the treatment of bad cholesterol, known as low-density lipoprotein (LDL) cholesterol, in certain adult patients with hypercholesterolemia. Praluent is the only EC-approved PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor that is available in two starting doses as a single 1-milliter (mL) injection (75 mg and 150 mg) once every two weeks, offering two levels of efficacy. Praluent will be available in a single-dose pre-filled pen that patients self-administer.
-
Self-assembled DNA nanostructures can be used in molecular-scale diagnostics and as smart drug-delivery vehicles.
Researchers from Aalto University have published an article in the recent Trends in Biotechnology journal. The article discusses how DNA molecules can be assembled into tailored and complex nanostructures, and further, how these structures can find uses in therapeutics and bionanotechnological applications. In the review article, the researchers outline the superior properties of DNA nanostructures, and how these features enable the development of efficient biological DNA-nanomachines. Moreover, these DNA nanostructures provide new applications in molecular medicine, such as novel approaches in tackling cancer. Tailored DNA structures could find targeted cells and release their molecular payload (drugs or antibodies) selectively into these cells.

